Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-11-12
    E.g., 2018-11-12

Articles

14734 items
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease ...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease ...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Techniques

This week in techniques

The Distillery: Techniques Approach Summary Licensing status Publication and contact information Assays & screens High throughput sequencing...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Techniques

This week in techniques

The Distillery: Techniques Approach Summary Licensing status Publication and contact information Assays & screens Monitoring early response...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Techniques

This week in techniques

The Distillery: Techniques Approach Summary Licensing status Publication and contact information Drug platforms Asymmetric RNA duplexes for...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Techniques

This week in techniques

The Distillery: Techniques Approach Summary Licensing status Publication and contact information Markers Serum-based cancer diagnostics ...
12:00 AM, Dec 11, 2008  |  BC Innovations | Targets & Mechanisms

Ad out

When Merck & Co Inc.'s V520 HIV vaccine failed in last year's Phase II STEP trial, it was the most advanced T cell-based HIV vaccine in development. Two research teams now have posited different theories...
12:00 AM, Dec 11, 2008  |  BC Innovations | Targets & Mechanisms

A SIAH of K-RAS relief

Researchers at the Mayo Clinic College of Medicine have shown that inhibiting the activity of an E3 ubiquitin ligase can inhibit cell proliferation and increase apoptosis across various types of lung and pancreatic cancers.1 The...
12:00 AM, Dec 11, 2008  |  BC Innovations | Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease ...

Pages